Rare diseases
Investigational molecules
Locations
Study of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative
BelgiumStudy of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
BelgiumStudy of ELVN-002 with Trastuzumab and Chemotherapy for Patients with Advanced HER2+ Solid Tumors, Colorectal Cancer, and Breast Cancer
BelgiumStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
BelgiumStudy of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor
BelgiumStudy of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant
BelgiumStudy of AMG 193 alone and combined with docetaxel for treatment of advanced MTAP-null solid tumors in adult patients
BelgiumStudy on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)
BelgiumStudy on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer
BelgiumStudy on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
BelgiumStudy of Nous-209 Genetic Vaccine and Pembrolizumab for Patients with Advanced Microsatellite Instability-High Colorectal Cancer
BelgiumStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
